title: [Benign-thyroid nodule: what's therapy? Personal experience].
abstract: BACKGROUND
  Solitary thyroid nodule is an important pathology with an incidence of 2-5% in Italian population. The diagnosis was based on clinical exam, laboratory tests and ultrasonographic evaluation.
  
  
  METHODS
  The study undertook has the purpose to assess the usefulness between lobe-isthmusectomy (with corresponding risk of possible relapse and complications for reintervention) and total thyroidectomy, (with corresponding post-surgical treatment complications), for benign thyroid disease with solitary nodule, on selected cases for disease and corresponding risk factors, in the retrospective clinical study, using laboratory tests and ultrasonographic evaluation. The study was conducted on 80 patients admitted from 1994 to 2000 with diagnosis of benign thyroid nodule and operated with lobeisthmusectomy. In seven patients the operation had to be converted in total thyroidectomy.
  
  
  RESULTS
  Operative mortality was nil and long-term results at a mean follow-up of three years are encouraging.
  
  
  CONCLUSIONS
  The main advantages of lobe-isthmusectomy for benign solitary thyroid nodule consist in less postoperative complications and less hospital stay.
  
  
  CONCLUSIONS
  Therefore our experience has carried us to consider the lobectomy which treatment choice for all those benign thyroid diseases, with, solitary nodule.
authors.affiliation: Università degli Studi di Catania, P.O.U. S. Luigi e S. Currò-Catania, Servizio Clinicizzato di Endocrinochirurgia.
authors.forename: M
authors.initials: M
authors.lastname: Costanzo
authors.forename: L A M
authors.initials: LA
authors.lastname: Caruso
authors.forename: D Carmelo
authors.initials: DC
authors.lastname: Messina
authors.forename: A
authors.initials: A
authors.lastname: Cavallaro
authors.forename: A
authors.initials: A
authors.lastname: Palumbo
authors.forename: M A
authors.initials: MA
authors.lastname: Cannizzaro
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012086:Reoperation; D012189:Retrospective Studies; D016606:Thyroid Nodule / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D013965:Thyroidectomy; D013974:Thyroxine / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D010919:Placebos; D013974:Thyroxine